锦好医疗
(872925)
| 流通市值：17.88亿 | | | 总市值：31.84亿 |
| 流通股本：5529.51万 | | | 总股本：9846.06万 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 113,433,441.47 | 55,628,550.27 | 186,077,884.38 | 107,242,146.61 |
| 营业收入 | 113,433,441.47 | 55,628,550.27 | 186,077,884.38 | 107,242,146.61 |
| 二、营业总成本 | 107,011,603.85 | 53,097,320.57 | 180,861,576.23 | 114,942,454.21 |
| 营业成本 | 65,182,277.19 | 32,447,719.61 | 98,304,118.85 | 55,936,832.41 |
| 税金及附加 | 770,075.78 | 348,872.69 | 2,454,193.3 | 857,074.42 |
| 销售费用 | 22,497,361.4 | 11,256,429.62 | 43,071,751.51 | 30,646,276.41 |
| 管理费用 | 8,144,882.17 | 3,716,877.22 | 15,209,568.15 | 10,404,355.42 |
| 研发费用 | 10,232,606.8 | 5,299,594.11 | 21,721,208.49 | 16,140,001.67 |
| 财务费用 | 184,400.51 | 27,827.32 | 100,735.93 | 957,913.88 |
| 其中:利息费用 | 489,085.47 | 198,470.4 | 478,165.31 | 149,646.03 |
| 其中:利息收入 | 706,327.7 | 394,105.87 | 592,106.69 | 492,852.91 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 11,506.85 | - | -692,364.38 | 166,383.56 |
| 加:投资收益 | 3,882.03 | -23,401.03 | 1,311,132.31 | 823,399.32 |
| 资产处置收益 | 50,002.16 | 43,328.92 | -1,955.95 | 9,306.53 |
| 资产减值损失(新) | -564,782.83 | -40,980.09 | -1,788,263.27 | 138,048.26 |
| 信用减值损失(新) | 151,267.13 | 99,191.36 | -1,557,012.69 | -305,126.49 |
| 其他收益 | 1,316,573.52 | 1,102,065.25 | 2,158,558.34 | 1,889,434.02 |
| 四、营业利润 | 7,390,286.48 | 3,711,434.11 | 4,646,402.51 | -4,978,862.4 |
| 加:营业外收入 | 670,555.37 | 441,064.76 | 160,499.71 | 134,832.44 |
| 减:营业外支出 | 24,233.52 | 9,058.79 | 60,414.22 | 231,196.41 |
| 五、利润总额 | 8,036,608.33 | 4,143,440.08 | 4,746,488 | -5,075,226.37 |
| 减:所得税费用 | 773,145.37 | 839,971.49 | 121,054.43 | 380,879.37 |
| 六、净利润 | 7,263,462.96 | 3,303,468.59 | 4,625,433.57 | -5,456,105.74 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 7,263,462.96 | 3,303,468.59 | 4,625,433.57 | -5,456,105.74 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 7,710,572.83 | 3,360,866.95 | 5,976,494.02 | -3,787,072.38 |
| 少数股东损益 | -447,109.87 | -57,398.36 | -1,351,060.45 | -1,669,033.36 |
| 扣除非经常损益后的净利润 | 6,544,372.01 | 2,503,947.19 | 3,614,556.51 | -5,558,068.39 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.08 | 0.03 | 0.06 | -0.04 |
| (二)稀释每股收益 | 0.08 | 0.03 | 0.06 | -0.04 |
| 八、其他综合收益 | 50,318.87 | -26,270.42 | -23,362.57 | -59,814.3 |
| 归属于母公司股东的其他综合收益 | 50,318.87 | -26,270.42 | -23,362.57 | -59,814.3 |
| 九、综合收益总额 | 7,313,781.83 | 3,277,198.17 | 4,602,071 | -5,515,920.04 |
| 归属于母公司股东的综合收益总额 | 7,760,891.7 | 3,334,596.53 | 5,953,131.45 | -3,846,886.68 |
| 归属于少数股东的综合收益总额 | -447,109.87 | -57,398.36 | -1,351,060.45 | -1,669,033.36 |
| 公告日期 | 2025-08-27 | 2025-04-29 | 2025-04-22 | 2024-10-29 |
| 审计意见(境内) | | | 标准无保留意见 | |